May 21, 2008 - European Resuscitation Council Symposium MEDIA CONTACT: Diane EganZOLL Medical Corporation+1 (978) email@example.com Kim AngelastroPublicis Consultants / PR+1 (212) firstname.lastname@example.org Distinguished Panel Discusses New Treatments for PEA and Intractable VF at European Resuscitation Council Lunchtime Symposium May 21, 2008—CHELMSFORD, Mass.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that it will host a lunchtime symposium entitled “Mostly Dead or Slighty Alive? —Not So Fast: New Treatments for PEA and Intractable VF” at the 9th Scientific Congress of the European Resuscitation Council in Ghent, Belgium. The session is scheduled from 12:30 p.m. to 1:45 p.m. Thursday, May 22nd in the Hubert van Eyck Room at the International Convention Center. The symposium will be moderated David Zideman, M.D., Consultant, Department of Anaesthetics, Imperial College Healthcare Trust, Hammersmith Hospital, London. Topics and speakers at the symposium include: “Arrest, Take a Rest”: Steen Barnung, M.D., Staff Specialist, Anaesthesiologist, Copenhagen Mobile Emergency Unit, Copenhagen, Denmark: This presentation will address the issue of how mechanical CPR provides new capabilities to keep perfusing patients over longer periods without extra staff, and the effect of fatigue and interruptions. “PEA: Is it Just an Illusion?”: Caleb Hernandez, M.D., Platte Valley Hospital, Colorado, United States: PEA is often an illusion and if diagnosed and treated may result in much better outcomes in this otherwise fatal rhythm. Treatment results have been excellent and this session will to promote the idea of aggressive treatment of PEA–more often than not considered untreatable. “To Intervene or Not to Intervene – That is the Question”: Levente Molnar, M.D., Interventional Cardiologist, Semmelweis University Heart Center, Budapest, Hungary; For the arrested patient who is not initially resuscitated for whatever reason—a feeling of survivability, a heart too good, a patient too young — patients in intractable VF are surviving with aggressive strategies of catheterization and revascularization while undergoing CPR. The issue of managing intra-catheterization cardiac arrest is also a topic of this session. “Slightly Alive vs. Mostly Alive: The Importance of What Happens after ROSC”: Kjetil Sunde, M.D., PhD., Department of Anaesthesiology and Institute for Experimental Medical Research, Ullevaal Univeristy Hospital, Oslo, Norway. Hypothermia and better post-resuscitation care mean significant improvements in survival. It is not enough to only pay attention to the immediate care. Patients are being lost everyday to ignorance and cynicism regarding survival from cardiac arrest. The question caregivers should be asking themselves is, “Are you leaving your patients only slightly alive?” To register for the event, go to www.zoll.com/erc. About ZOLL Medical Corporation ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See Thru CPR™, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information. ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information, visit www.zoll.com. Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on February 5, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements. Copyright © 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AED Plus, AED Pro, AutoPulse, CodeNet, E Series, LifeBand, M Series, Power Infuser and Real CPR Help are registered trademarks of ZOLL Medical Corporation. Code-Ready, One-Step, See-Thru CPR and R Series are trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners. *Ong ME, Ornato JP et al. JAMA. 2006;295(22) .